Merck Millipore announces co-marketing agreement with Groninger for single-use filling solutions
The agreement combines single-use assemblies, sterility assurance solutions and stainless steel filling equipment
Merck Millipore, the life science division of Merck KGaA of Darmstadt, Germany, has announced a co-marketing agreement with Groninger, a provider of filling and packaging equipment for the pharmaceutical industry headquartered in Crailsheim.
Under the terms of the non-exclusive agreement, Merck Millipore will provide single-use filling products for use with Groninger's liquid filling equipment.
Merck Millipore says its Mobius single-use final fill assemblies offer greater flexibility than traditional options, allowing biopharmaceutical manufacturers to produce a variety of drug products and fill volumes with reduced process turnaround time and higher productivity. By combining these products with Groninger’s liquid fill equipment, the co-marketing agreement will help customers accelerate the development and time-to-market of biopharmaceutical therapeutics.
‘The biopharmaceutical industry is facing increasingly complex drug production demands, as therapeutic drugs in development have smaller lot sizes and highly potent ingredients,’ said Vin Donovan, Vice President of Biopharm Process Solutions.
‘This new partnership will allow us to help our customers address these new challenges while ensuring the safety of their filling operations.’
Merck Millipore offers a full range of products, including Durapore and Millipore Express membranes for sterile filtration, the NovaSeptum system for sterile sampling, the Lynx family of sterile connectors and Provantage services for sterility training and qualification.